Home » Topics » BioWorld Science

BioWorld Science
RSS

NanoSurface announces NIH funding to support iPSC-based platform development

March 4, 2020

Update for part A of ongoing phase I/IIa study of VBI-1901

March 4, 2020

Zydus receives approval to initiate phase I study of ZYBK-2 in India

March 4, 2020

GBV-6249-192 demonstrates good preclinical results for treating primary open-angle glaucoma

March 4, 2020

Nanoparticle vaccine elicits HBV therapeutic response

March 4, 2020

Medshine Discovery discloses new PI3K inhibitors

March 4, 2020

Complement factor D inhibitors identified at Achillion

March 4, 2020

First patient dosed in multiple ascending dose phase I study of LYT-100

March 4, 2020

Modern Biosciences patents anti-cancer compounds

March 4, 2020

New NLRP3 agonists discovered at Innate Tumor Immunity

March 4, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...